RETA/CAG is a retatrutide + cagrilintide dual research blend (12.5 mg + 2.5 mg) — not a dual-strength GLP-3 RT kit. VaultLabs supplies RETA/CAG (15 mg blend) for in vitro laboratory workflows in the UAE — not for human consumption or medical application.
RETA/CAG is a dual-component lyophilized research blend of retatrutide (12.5 mg) and cagrilintide (2.5 mg) in a 15 mg catalog unit — not a dual-strength GLP-3 RT kit. VaultLabs supplies this retatrutide + cagrilintide blend for comparative in vitro laboratory studies with independent lot tracking from single-sequence GLP-3 RT SKUs. Strictly for qualified analytical research — not for human or animal consumption.
GLP-3 RT 10mg (also searched as Reta / Retatrutide) is VaultLabs catalog naming for retatrutide lyophilized research material. Distinct from the RETA/CAG retatrutide + cagrilintide blend. Lot-tracked powder for controlled in vitro laboratory workflows across the UAE — not for human or animal consumption.
KLOW is a multi-component lyophilized research blend combining BPC-157 (10 mg), GHK-Cu (50 mg), TB-500 (10 mg), and KPV (10 mg) as a single catalog reference for comparative in vitro laboratory studies. Each blend lot is traceable with documentation published when available. Strictly for qualified analytical research — not for human or animal consumption.
The live catalog SKU is RETA/CAG 15 mg: retatrutide 12.5 mg plus cagrilintide 2.5 mg in one lyophilized vial. It is not a two-vial GLP-3 RT pack and it does not share lots with GLP-3 RT 10 mg / 20 mg.
If the research design needs single-sequence retatrutide only, use the Retatrutide UAE procurement overview and the GLP-3 RT product record. Use RETA/CAG only when the combination itself is the documentation object.
The RETA/CAG monograph explains why a blend has no single CAS number and why a single purity percentage cannot describe both components.
Documentation and batch verification
Match the vial lot to batch verification before the unit enters an experiment. A GLP-3 RT certificate must not be applied to a RETA/CAG vial.
Read the COA interpretation guide when reviewing blend records: the useful questions are whether both named components are identifiable, not whether one main peak looks clean.
Contact support if a lot is not yet published. Lot-linked records override generic catalog copy for the unit in hand.
Storage and UAE dispatch
Sealed RETA/CAG is stored at 2–8 °C, protected from light and moisture, then transferred promptly to laboratory storage after UAE receiving. See the research peptide storage guide.
VaultLabs dispatches across all emirates from the research peptides UAE hub. Packaging is selected for lyophilized research material, not for clinical cold-chain claims.
Research-use-only positioning
RETA/CAG is not intended for human consumption, medical use, or personal application. VaultLabs provides no dosing or administration guidance.
Materials are for qualified in vitro laboratory research only. Use the product page for current AED pricing and availability.
Frequently asked questions
All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.